HYPR · Insider Trading
Hyperfine, Inc. Class A Common Stock
Every open-market purchase and sale reported by HYPR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | Brett Hale | CFO and CAO | Sell | −7,345 | −$6.27K |
| 2026-08-25 | Thomas Teisseyre | Chief Operating Officer | Sell | −7,345 | −$6.27K |
| 2022-08-16 | Neela Paykel | Gen Counsel & Corp Secretary | Sell | −1,891 | −$2.74K |
| 2022-08-16 | Khan Siddiqui | CMO and Chief Strategy Officer | Sell | −1,035 | −$1.50K |
| 2022-08-16 | Alok Gupta | Chief Financial Officer | Sell | −8,871 | −$12.86K |
| 2022-08-16 | Jonathan M Rothberg | Director | Buy | +64,213 | +$95.16K |
| 2022-08-12 | Jonathan M Rothberg | Director | Buy | +303,137 | +$441.67K |
| 2022-07-06 | Khan Siddiqui | CMO and Chief Strategy Officer | Sell | −4,846 | −$9.79K |
| 2022-07-06 | Neela Paykel | Gen Counsel & Corp Secretary | Sell | −10,542 | −$21.29K |
| 2022-06-15 | Jonathan M Rothberg | Director | Buy | +52,848 | +$119.44K |
| 2022-06-13 | Ruth A Fattori | Director | A | +85,345 deriv. | — |
| 2022-06-13 | R Scott Huennekens | Director | A | +85,345 deriv. | — |
| 2022-06-13 | John T Dahldorf | Director | A | +85,345 deriv. | — |
| 2022-06-13 | Maria Sainz | Director | A | +85,345 deriv. | — |
| 2022-06-13 | Jonathan M Rothberg | Director | A | +85,345 deriv. | — |
| 2022-06-13 | Dan Wolterman | Director | A | +85,345 deriv. | — |
| 2022-04-28 | David D Scott | President and CEO | A | +649,350 | — |
| 2022-03-31 | Khan Siddiqui | CMO and Chief Strategy Officer | A | +92,000 | — |
| 2022-03-31 | Alok Gupta | Chief Financial Officer | A | +127,167 | — |
| 2022-03-31 | Scott A. White | Chief Commercial Officer | A | +96,875 | — |
| 2022-03-31 | David D Scott | President and CEO | A | +150,000 | — |
| 2022-03-31 | Neela Paykel | Gen Counsel & Corp Secretary | A | +127,500 | — |
| 2022-03-31 | R Scott Huennekens | Director | A | +237,437 deriv. | — |
| 2022-03-09 | Ruth A Fattori | Director | A | +100,000 deriv. | — |
| 2022-02-11 | Khan Siddiqui | Chief Medical Officer and CSO | A | +184,000 deriv. | — |
| 2022-02-11 | Scott A. White | Chief Commercial Officer | A | +193,750 deriv. | — |
| 2022-02-11 | Alok Gupta | Chief Financial Officer | A | +254,333 deriv. | — |
| 2022-02-11 | Mark A. Hughes | Chief Operating Officer | A | +45,000 deriv. | — |
| 2022-02-11 | Neela Paykel | Gen Counsel & Corp Secretary | A | +156,750 deriv. | — |
| 2022-01-10 | Maria Sainz | Director | A | +19,586 | — |
| 2022-01-10 | John T Dahldorf | Director | A | +19,586 | — |
| 2022-01-10 | R Scott Huennekens | Director | A | +19,586 | — |
| 2022-01-10 | Ruth A Fattori | Director | A | +20,477 | — |
| 2022-01-10 | Jonathan M Rothberg | Director | A | +16,300,487 | — |
| 2022-01-10 | Dan Wolterman | Director | A | +19,586 | — |
| 2021-12-27 | HC Sponsor LLC | 10%+ Owner | MIXED | +26,136,000 | — |
| 2021-12-23 | Neela Paykel | Gen Counsel & Corp Secretary | A | +98,250 deriv. | — |
| 2021-12-23 | Dan Wolterman | Director | A | +16,483 | — |
| 2021-12-23 | David D Scott | Chief Executive Officer | A | +2,849,250 deriv. | — |
| 2021-12-23 | Mark A. Hughes | Chief Operating Officer | A | +19,615 | — |
| 2021-12-23 | Jonathan M Rothberg | Director | A | +16,297,384 | — |
| 2021-12-23 | Khan Siddiqui | CMO and Chief Strategy Officer | A | +290,978 deriv. | — |
| 2021-12-23 | R Scott Huennekens | Director | A | +16,483 | — |
| 2021-12-23 | Ruth A Fattori | Director | A | +17,374 | — |
| 2021-12-23 | John T Dahldorf | Director | A | +16,483 | — |
| 2021-12-23 | Maria Sainz | Director | A | +16,483 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Thomas Teisseyre | Chief Operating Officer | 671,256 | $481.69K |
| Brett Hale | CFO and CAO | 592,420 | $425.12K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HYPR quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.